Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors.
OBJECTIVE
Photon therapy has been reported to induce resets of implanted cardiac devices, but the clinical sequelae of treating patients with such devices with proton beam therapy (PBT) are not well known. We reviewed the incidence of device malfunctions among patients undergoing PBT.


METHODS
From March 2009 through July 2012, 42 patients with implanted cardiac implantable electronic devices (CIED; 28 pacemakers and 14 cardioverter-defibrillators) underwent 42 courses of PBT for thoracic (23, 55%), prostate (15, 36%), liver (3, 7%), or base of skull (1, 2%) tumors at a single institution. The median prescribed dose was 74 Gy (relative biological effectiveness; range 46.8-87.5 Gy), and the median distance from the treatment field to the CIED was 10 cm (range 0.8-40 cm). Maximum proton and neutron doses were estimated for each treatment course. All CIEDs were checked before radiation delivery and monitored throughout treatment.


RESULTS
Median estimated peak proton and neutron doses to the CIED in all patients were 0.8 Gy (range 0.13-21 Gy) and 346 Sv (range 11-1100 mSv). Six CIED malfunctions occurred in 5 patients (2 pacemakers and 3 defibrillators). Five of these malfunctions were CIED resets, and 1 patient with a defibrillator (in a patient with a liver tumor) had an elective replacement indicator after therapy that was not influenced by radiation. The mean distance from the proton beam to the CIED among devices that reset was 7.0 cm (range 0.9-8 cm), and the mean maximum neutron dose was 655 mSv (range 330-1100 mSv). All resets occurred in patients receiving thoracic PBT and were corrected without clinical incident. The generator for the defibrillator with the elective replacement indicator message was replaced uneventfully after treatment.


CONCLUSIONS
The incidence of CIED resets was about 20% among patients receiving PBT to the thorax. We recommend that PBT be avoided in pacing-dependent patients and that patients with any type of CIED receiving thoracic PBT be followed closely.
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: dgomez@mdanderson.org.
Daniel R
DR
Gomez
Falk
F
Poenisch
Chelsea C
CC
Pinnix
Tommy
T
Sheu
Joe Y
JY
Chang
Nada
N
Memon
Radhe
R
Mohan
Marc A
MA
Rozner
Anne H
AH
Dougherty
D000075202:Contraindications; D017147:Defibrillators, Implantable; D004868:Equipment Failure / Q000706:statistics & numerical data*; D019544:Equipment Failure Analysis; D006801:Humans; D008113:Liver Neoplasms / Q000532:radiotherapy; D008297:Male; D009502:Neutrons / Q000009:adverse effects / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D011471:Prostatic Neoplasms / Q000532:radiotherapy; D061766:Proton Therapy; D011879:Radiotherapy Dosage; D012062:Relative Biological Effectiveness; D012189:Retrospective Studies; D013899:Thoracic Neoplasms / Q000532:radiotherapy